Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The ADIPOSA Study
NCT05612594Phase 4Recruiting
- Sponsor
- Yale University
- Start
- Mar 2024
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in obstructive sleep apnea (OSA) comparing Bexagliflozin with Placebo (2 arms). Primary endpoint: Apnea-Hypopnea Index at 6 months. Started Mar 2024; status: recruiting.
02
Drugs
bexagliflozin
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT05612594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05612594.